BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,788,772 | -9.4% | 7,990,000 | -8.6% | 0.02% | -11.1% |
| Q2 2023 | $8,597,136 | -4.5% | 8,740,000 | -1.1% | 0.03% | -15.6% |
| Q1 2023 | $9,004,111 | -10.3% | 8,840,000 | -5.9% | 0.03% | -11.1% |
| Q4 2022 | $10,034,515 | +8.2% | 9,390,000 | +1.5% | 0.04% | -16.3% |
| Q3 2022 | $9,275,000 | -21.5% | 9,250,000 | -22.3% | 0.04% | -14.0% |
| Q2 2022 | $11,818,000 | -4.9% | 11,900,000 | -4.0% | 0.05% | +16.3% |
| Q1 2022 | $12,431,000 | +14.1% | 12,400,000 | +19.2% | 0.04% | +22.9% |
| Q4 2021 | $10,896,000 | -12.7% | 10,400,000 | -14.8% | 0.04% | -20.5% |
| Q3 2021 | $12,479,000 | -9.5% | 12,200,000 | -8.2% | 0.04% | -10.2% |
| Q2 2021 | $13,796,000 | -2.1% | 13,295,000 | -3.2% | 0.05% | -21.0% |
| Q1 2021 | $14,091,000 | -0.4% | 13,740,000 | +3.8% | 0.06% | 0.0% |
| Q4 2020 | $14,143,000 | +20.3% | 13,240,000 | +17.8% | 0.06% | +34.8% |
| Q3 2020 | $11,760,000 | +53.7% | 11,240,000 | +80.1% | 0.05% | +17.9% |
| Q2 2020 | $7,652,000 | -11.3% | 6,240,000 | -24.8% | 0.04% | -30.4% |
| Q1 2020 | $8,629,000 | +22.7% | 8,300,000 | +23.9% | 0.06% | +143.5% |
| Q4 2019 | $7,034,000 | -4.5% | 6,700,000 | -10.1% | 0.02% | -14.8% |
| Q3 2019 | $7,364,000 | +2.6% | 7,450,000 | +7.2% | 0.03% | +3.8% |
| Q2 2019 | $7,180,000 | +138.0% | 6,950,000 | +135.6% | 0.03% | +136.4% |
| Q1 2019 | $3,017,000 | +2.9% | 2,950,000 | 0.0% | 0.01% | -15.4% |
| Q4 2018 | $2,931,000 | -74.6% | 2,950,000 | -73.1% | 0.01% | -69.0% |
| Q3 2018 | $11,555,000 | -24.1% | 10,950,000 | -27.0% | 0.04% | -33.3% |
| Q2 2018 | $15,227,000 | +2.9% | 15,000,000 | -4.5% | 0.06% | -7.4% |
| Q1 2018 | $14,795,000 | – | 15,700,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |